Stay updated with breaking news from Immunext Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MSHigh-dose frexalimab significantly reduced dis...
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The
Positive Phase 2 data of novel investigational anti-CD40L antibody frexalimab show significantly reduced disease activity in relapsing multiple sclerosis Frexalimab met primary
/PRNewswire/ -- The global immunology market size is estimated to grow by USD 56.07 billion from 2022 to 2027, according to Technavio. The market is estimated...
Press release content from PR Newswire. The AP news staff was not involved in its creation. Lilly Reports Strong Fourth-Quarter and Full-Year 2020 Financial Results January 29, 2021 GMT Eli Lilly and Company logo. (PRNewsfoto/Eli Lilly and Company) INDIANAPOLIS, Jan. 29, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced financial results for the fourth quarter and full year of 2020. $ in millions, except 31% Certain financial information for 2020 and 2019 is presented on both a reported and a non-GAAP basis. Some numbers in this press release may not add due to rounding...